Sumitomo Mitsui Trust Group
AGN

Sumitomo Mitsui Trust Group’s Allergan Inc AGN Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-703,237
Closed -$150M – 914
2014
Q4 		$150M Sell
703,237
-10,977
-2% -$2.18M 0.29% 76
2014
Q3 		$127M Buy
714,214
+9,435
+1% +$1.57M 0.26% 94
2014
Q2 		$119M Sell
704,779
-34,561
-5% -$5.38M 0.24% 98
2014
Q1 		$91.8M Sell
739,340
-14,957
-2% -$1.82M 0.19% 128
2013
Q4 		$83.5M Sell
754,297
-18,704
-2% -$1.79M 0.17% 144
2013
Q3 		$69.9M Sell
773,001
-9,258
-1% -$831K 0.15% 153
2013
Q2 		$65.9M Buy
+782,259
New +$81.2M 0.15% 155

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group's AGN Position: Q1 2015 in Review

Sumitomo Mitsui Trust Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 703,237 shares — an estimated $150M sold.

Sumitomo Mitsui Trust Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $150M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Sumitomo Mitsui Trust Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 703,237 Allergan Inc shares in Q1 2015, an estimated $150M.
  • Sumitomo Mitsui Trust Group first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Sumitomo Mitsui Trust Group's Allergan Inc position peaked at $150M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2015, filed 8 May 2015.